# Effectiveness and Safety of Lactobacillus Acidophilus LA85 in Preventing Antibiotic-Associated Diarrhea

> **NCT05974657** · NA · COMPLETED · sponsor: **Wecare Probiotics Co., Ltd.** · enrollment: 82 (actual)

## Conditions studied

- Antibiotic Side Effect
- Probiotics
- Diarrhea

## Interventions

- **OTHER:** Probiotic Lactobacillus acidophilus LA85

## Key facts

- **NCT ID:** NCT05974657
- **Lead sponsor:** Wecare Probiotics Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-31
- **Primary completion:** 2022-08-03
- **Final completion:** 2022-09-13
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2023-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05974657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05974657, "Effectiveness and Safety of Lactobacillus Acidophilus LA85 in Preventing Antibiotic-Associated Diarrhea". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05974657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*